Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neuroblastoma × Lenalidomide × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Smoldering Multiple Myeloma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1

Interventions

gallium Ga 68 dotatate 2 naxitamab 1 fludarabine 1 eliglustat 1 Vaccines, DNA 1 Thiotepa 1 Temozolomide 1 Rituximab 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Irinotecan 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Ga(III)-DOTATOC 1 6-fluorodopamine 1 3-fluorobenzylguanidine 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡